Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA02000247 12(13)-Epoxy-9-oxo-OME 9-oxo-12,13-epoxy-10-octadecenoic acid FA 18:3;O2 C18H30O4 310.214411
LMFA02000247 12(13)-Epoxy-9-oxo-OME 9-oxo-12,13-epoxy-10-octadecenoic acid FA 18:3;O2 C18H30O4 310.214411
LMFA03030012 2,3-Dinor-TXB1 9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid FA 18:2;O4 C18H32O6 344.219891
LMFA03030012 2,3-Dinor-TXB1 9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid FA 18:2;O4 C18H32O6 344.219891
LMFA03030012 2,3-Dinor-TXB1 9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid FA 18:2;O4 C18H32O6 344.219891
LMFA03030012 2,3-Dinor-TXB1 9S,11,15S-trihydroxy-2,3-dinor-thrombox-13E-en-1-oic acid FA 18:2;O4 C18H32O6 344.219891
LMFA02000416 Eiseniachloride B 1R,2S,12Z,14S,15R,16R)-16-chloro-2-ethyl-15-hydroxy-3-oxabicyclo[12.3.0]heptadeca-12-en-4-one C18H29O3Cl 328.180524
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA02030077 16-F2t-PhytoP-SDA 8-((1S,2S,3R,5R)-3,5-dihydroxy-2-(3S-hydroxypent-1E-en-1-yl)cyclopentyl)-6Z-octenoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA02030078 6-F2t-PhytoP-SDA 8-((1S,2S,3R,5R)-3,5-dihydroxy-2-(pent-2Z-en-1-yl)cyclopentyl)-6S-hydroxy-7E-octenoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA02030079 6-F1t-PhytoP-GLA 8-((1S,2S,3R,5R)-3,5-dihydroxy-2-(pentan-1-yl)cyclopentyl)-6S-hydroxy-7E-octenoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA02040133 ent16-(R,S)-13-epi-ST-delta14-9-PhytoF 8-((2R,3S,5R)-5-((1S,4,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid FA 18:2;O4 C18H32O6 344.219891
LMFA04030012 Resolvin D3 4S,11R,17S-trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030012 Resolvin D3 4S,11R,17S-trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030012 Resolvin D3 4S,11R,17S-trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA07010351 Geranylgeranyl acetate 3,7,11,15-Tetramethyl-2E,6E,10E,14-hexadecatetraenyl acetate SFE 22:4 C22H36O2 332.271531
LMFA04030008 AT-Resolvin D3 4S,11R,17R- trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic-acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030008 AT-Resolvin D3 4S,11R,17R- trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic-acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030008 AT-Resolvin D3 4S,11R,17R- trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic-acid FA 22:6;O3 C22H32O5 376.224976
LMFA03080025 (+/-)11,12-EpETrE-d11 (+-)11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080025 (+/-)11,12-EpETrE-d11 (+-)11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080025 (+/-)11,12-EpETrE-d11 (+-)11(12)-epoxy-5Z,8Z,14Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA01050101 Aleuritic acid 9,10,16-trihydroxy-hexadecanoic acid FA 16:0;O3 C16H32O5 304.224976
LMFA07010549 WE 14:0(6Me,10Me,13Me)/4:0(3Me) 6,10,13-Trimethyltetradecyl 3-methylbutanoate WE 22:0 C22H44O2 340.334131
LMFA07010549 WE 14:0(6Me,10Me,13Me)/4:0(3Me) 6,10,13-Trimethyltetradecyl 3-methylbutanoate WE 22:0 C22H44O2 340.334131
LMFA07010548 (E,E)-farnesyl nonanoate (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl nonanoate WE 24:3 C24H42O2 362.318481